Journal: Cancer Communications
Article Title: The Ly6g high Neutrophil Subset Dictates Breast Cancer Lung Metastasis via CD8 + T Cell Death
doi: 10.34133/cancomm.0003
Figure Lengend Snippet: Cathelicidin binding to ANT1 induces mPTP opening and promotes apoptosis in CD8 + T cell. (A) CD8 + T cells isolated from WT mice were treated with NETs derived from WT or Cramp −/− mice, or with Cramp, and then stained with JC-1. ΔΨm was determined by flow cytometry ( n = 4). The bar graph on the right shows the decreased ΔΨm of CD8 + T cells. (B) Representative immunofluorescence images showing colocalization of Cramp (green) with mitochondria (red) in CD8 + T cells by confocal laser microscopy. (C and D) CD8 + T cells were treated with vehicle (cell-free culture medium), NETs derived from WT or Cramp −/− mice, or Cramp. Cytoplasmic and mitochondrial ROS were measured using DCFH-DA and MitoSOX red probes [ n = 5, (C)]. Representative transmission electron microscopic images of mitochondrial ultrastructure in CD8 + T cells under the indicated treatments (D). Red arrows point to mitochondria exhibiting swelling, disorganized cristae, and loss of membrane integrity. (E) Mouse or human CD8 + T cells were treated with Cramp or LL37. The mPTP opening of mitochondria was measured by calcein loading/CoCl 2 quenching. (F) Protein–protein interactions were assessed in vitro using a pull-down assay. Recombinant proteins Ant1 (or Vdac1) and biotin-labeled Cramp (or a cecropin-like antibacterial peptide from Helicobacter pylori ) were used for this purpose. (G) Co-IP was used to check the interaction between mitochondrial protein Ant1 and Vdac1 in mouse CD8 + T cells under the treatment with different concentrations of NETs derived from WT and Cramp − / − mice ( n = 3). (H and I) Mouse CD8 + T cells were treated with Cramp or Cramp combined with different concentrations of BKA ( n = 4). (H) The interaction between mitochondrial protein Ant1 and Vdac1 in CD8 + T cells was assessed by Co-IP. (I) The ΔΨm of mitochondria in CD8 + T cells was assessed by flow cytometry after staining with JC-1. (J) CD8 + T cells were treated as in (I), and CD8 + T cell apoptosis was quantified by flow cytometry ( n = 4). The bar graph on the right shows the apoptosis of CD8 + T cells. The data with error bars are presented as the mean ± SD; statistical significance was determined by one-way ANOVA test (A, C, I, and J). ANOVA, analysis of variance; Ant1, adenine nucleotide translocator 1; BKA, bongkrekic acid; CD8, cluster of differentiation 8; Co-IP, coimmunoprecipitation; Cramp, cathelicidin antimicrobial peptide; Cyto, cytoplasm; DAPI, 4’,6-diamidino-2-phenylindole; DCFH-DA, 2′,7′-dichlorodihydrofluorescein diacetate; Hp, Helicobacter pylori ; kDa, kilodalton; Mito, mitochondrial; mPTP, mitochondrial permeability transition pore; NETs, neutrophil extracellular traps; PI, propidium iodide; ROS, reactive oxygen species; Vdac1, voltage dependent anion channel 1; WT, wild type; SD, standard deviation; ΔΨm, mitochondrial membrane potential.
Article Snippet: To assess CD8 + T cell infiltration in the lung mTME, mice were treated daily with the PADI4 inhibitor GSK484 (20 mg/kg) and administered intranasally with either Cramp (30 mg/kg, 376364-36-2, Go Top Peptide Biotech, Hangzhou, Zhejiang, China) or bongkrekic acid (BKA; 200 μg/kg, HY-136406, MedChemExpress) 3 times per week after E0771-LM3 cell injection, continuing to the macrometastatic stage.
Techniques: Binding Assay, Isolation, Derivative Assay, Staining, Flow Cytometry, Immunofluorescence, Microscopy, Transmission Assay, Membrane, Protein-Protein interactions, In Vitro, Pull Down Assay, Recombinant, Labeling, Co-Immunoprecipitation Assay, Permeability, Standard Deviation